Encompass Health announces private offering of senior notes

Rhea-AI Summary

Encompass Health (NYSE:EHC) has launched a private offering of $500 million in senior notes maturing in 2034. The notes will be guaranteed on a senior unsecured basis by subsidiaries that guarantee the company’s credit agreement and other capital markets debt.

According to Encompass Health, net proceeds and cash on hand will be used to redeem $400 million of 4.500% senior notes due 2028 at par, repay $100 million under its senior secured revolving credit facility, and cover related fees and expenses.

Positive

• Plans to issue $500 million of senior notes maturing in 2034
• Intends to redeem $400 million of 4.500% senior notes due 2028 at par
• Intends to repay $100 million outstanding under the senior secured revolving credit facility

Negative

• New senior notes create long-term debt obligations through 2034
• Offering is a private placement, limiting direct participation to qualified institutional buyers and certain non-U.S. investors

News Market Reaction – EHC

-0.18%

-0.18% Session close to close

In the May 14 session, EHC declined 0.18%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines a private offering of $500 million in senior notes maturing in 2034, with...

Analysis

This announcement outlines a private offering of $500 million in senior notes maturing in 2034, with proceeds earmarked to redeem $400 million of 4.500% notes due 2028 and repay $100 million on the revolving credit facility. It follows solid Q1 2026 results, including net operating revenue of $1,586.6M and EPS of $1.77. Investors may track how this refinancing affects interest expense, maturity profile, and flexibility for continued hospital expansion and dividends.

Key Figures

Senior notes offering: $500 million Notes redemption: $400 million Revolver repayment: $100 million +5 more

8 metrics

Senior notes offering $500 million Aggregate principal amount of new senior notes maturing 2034

Notes redemption $400 million Par redemption of 4.500% Senior Notes due 2028

Revolver repayment $100 million Repayment of senior secured revolving credit facility

Legacy coupon rate 4.500% Coupon on Senior Notes due 2028 to be redeemed

Net operating revenue $1,586.6M Q1 2026, up 9.0% year over year

Adjusted EBITDA $348.8M Q1 2026, up 11.2% year over year

EPS (continuing ops) $1.77 Q1 2026, up 19.6% year over year

Quarterly dividend $0.19 per share Declared May 7, 2026, payable July 15, 2026

Historical Context

5 past events · Latest: May 11 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 11	New hospital plan	Positive	+3.1%	Announced plans for a new 50-bed inpatient rehab hospital in Idaho.
May 07	Dividend declaration	Positive	+2.0%	Board declared a quarterly cash dividend of $0.19 per share.
May 05	Hospital opening	Positive	-0.1%	Opened a new 50-bed rehabilitation hospital in Pennsylvania.
Apr 30	Earnings release	Positive	+7.5%	Reported Q1 2026 revenue, EBITDA and EPS growth with raised guidance.
Apr 23	Conference participation	Neutral	+0.1%	Announced participation in a major health care investor conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent fundamentally positive news (earnings, expansion, dividends) has often aligned with positive price reactions, with only one mild divergence.

Recent Company History

Over the past month, Encompass Health has combined solid operating results with network expansion and shareholder returns. Q1 2026 results on Apr 30 showed net operating revenue of $1,586.6M (up 9.0%) and Adjusted EBITDA of $348.8M (up 11.2%), prompting a 7.48% gain. A quarterly dividend of $0.19 per share on May 7 and hospital growth announcements on May 5 and May 11 also drew mostly positive reactions. Today’s private senior-notes offering fits into this backdrop of active capital and growth management.

Key Terms

senior notes, senior unsecured, revolving credit facility, Rule 144A, +1 more

5 terms

senior notes financial

"announced it has commenced a private offering of $500 million in aggregate principal amount of senior notes"

Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.

senior unsecured financial

"guaranteed on a senior unsecured basis by all of the Company's existing and future subsidiaries"

Senior unsecured is a type of loan or bond that has priority over other unsecured obligations for repayment if a company runs into financial trouble, but it is not backed by specific assets as collateral. Think of it as being near the front of a line to get paid, but without a pledged item to seize if the borrower defaults; that higher repayment priority typically makes it less risky than subordinated debt but more risky than secured debt, which influences the interest rate investors demand.

revolving credit facility financial

"to repay $100 million of the outstanding amounts under the Company's senior secured revolving credit facility"

A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.

Rule 144A regulatory

"to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933"

Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.

Regulation S regulatory

"and to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act"

Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of $500 million in aggregate principal amount of senior notes maturing in 2034 (the "Notes"), subject to market and other conditions. The Notes will be jointly and severally guaranteed on a senior unsecured basis by all of the Company's existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt.

The Company intends to use the net proceeds from the offering of the Notes, together with available cash on hand, to redeem at par $400 million in aggregate principal amount of its outstanding 4.500% Senior Notes due 2028, to repay $100 million of the outstanding amounts under the Company's senior secured revolving credit facility and to pay certain related fees and expenses in connection with the foregoing.

The Notes will be offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act. The offer and any sale of the Notes and the related guarantees have not been and will not be registered under the Securities Act or any state securities laws, and the Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security and does not constitute an offer, solicitation or sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful. This press release shall not constitute a notice of redemption with respect to the notes to be redeemed.

About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.

From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.

Forward-looking statements
Statements contained in this press release which are not historical facts, such as the likelihood, timing and effects of the completion of the private offering of the Notes, are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, Encompass Health's ability to complete the offering of the Notes on the terms described or at all; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant disruption in the capital markets or economy; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2025 and Form 10-Q for the quarter ended March 31, 2026.

Media contact:  
Polly Manuel | 205-970-5912
Media@encompasshealth.com 

Investor relations contact:
Mark Miller | 205-970-5860
Mark.Miller@encompasshealth.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-private-offering-of-senior-notes-302772410.html

SOURCE Encompass Health Corp.

FAQ

What did Encompass Health (NYSE:EHC) announce about its senior notes on May 14, 2026?

Encompass Health announced a private offering of $500 million senior notes maturing in 2034. According to Encompass Health, the notes will be guaranteed on a senior unsecured basis by certain existing and future subsidiaries.

How will Encompass Health use the proceeds from its 2026 $500 million senior notes offering (EHC)?

Encompass Health intends to use proceeds to redeem $400 million of 4.500% notes due 2028 and repay $100 million on its revolver. According to Encompass Health, remaining funds will cover related fees and expenses.

Who can buy Encompass Health’s new 2034 senior notes (NYSE:EHC)?

The notes are being offered privately to qualified institutional buyers in the U.S. under Rule 144A and certain non-U.S. investors under Regulation S. According to Encompass Health, the securities will not be registered under the Securities Act.

Are Encompass Health’s 2026 senior notes (EHC) registered with the SEC?

The new senior notes and guarantees will not be registered under the Securities Act or state securities laws. According to Encompass Health, they cannot be offered or sold in the U.S. without registration or a valid exemption.

What existing Encompass Health debt will be affected by the new 2034 senior notes (EHC)?

Encompass Health plans to redeem $400 million of its 4.500% senior notes due 2028 and repay $100 million of borrowings under its senior secured revolving credit facility. According to Encompass Health, proceeds will also fund related fees.

Does the Encompass Health (EHC) press release constitute an offer to sell the new notes?

The announcement does not constitute an offer to sell or a solicitation to buy any security. According to Encompass Health, no offer or sale will occur where it would be unlawful, and this release is not a redemption notice.